The Drugs Controller General of India (DCGI) has formally announced the final approval for Oxford-AstraZeneca “Covishield” and Bharat Biotech “Covaxin” vaccines against the coronavirus disease (Covid-19) for emergency use. CDSCO (Central Drugs Standard Control Organisation) accepts the subject expert committee reform rations on Serum and Bharat Biotech Covid vaccines.
About Covishield:
The subject expert committee (SEC) under CDSCO had recommended Oxford-AstraZeneca’s vaccine, which is being manufactured by the Serum Institute of India (SII) as Covishield, for emergency use and Covaxin for restricted use.
About Covaxin:
Covaxin is the indigenous vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).
Important takeaways for all competitive exams:
Dr Colleen Begg from South Africa has won the 2026 Prince William Award for Conservation…
Professor Shekhar C. Mande, President of the Indian National Science Academy (INSA), has been appointed…
The winners of the National Gopal Ratna Awards (NGRA) 2026 have been announced. It aims…
Four cheetah cubs have been born to a female cheetah in the wild, increasing the…
India has developed its very own H5N1 subtype Bird Flu Vaccine for Chickens. On November…
On 20 th November 2026, the Prime Minister Narendra Modi formally opened the First Shanghai…